CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Interpharm Holdings, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Interpharm Holdings, Inc.
75 Adams Ave
Phone: (631) 952-0214p:631 952-0214 HAUPPAUGE, NY  11788  United States Ticker: IPAHIPAH

This company ceased filing statements with the SEC on 5/13/2008.

Business Summary
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20076/30/2007YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Maganlal K.Sutaria 77 1/25/2005 5/29/2003
Chief Financial Officer, Chief Operating Officer, Executive Vice President PeterGiallorenzo 62 7/10/2007 2/15/2007
Executive Vice President, General Counsel Kenneth M.Cappel 46 3/30/2006 3/30/2006
7 additional Officers and Directors records available in full report.

Business Names
Business Name
Innovative Business Micros, Inc.
Interpharm Realty, LLC
Interpharm, Inc.
4 additional Business Names available in full report.

General Information
Number of Employees: 670 (As of 6/30/2007)
Outstanding Shares: 66,738,426 (As of 12/31/2018)
Shareholders: 167
Stock Exchange: OTC
Federal Tax Id: 133673965
Fax Number: (914) 949-9618


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023